Follow Us:

News

Industry News

Anticholinergic and emergency treatment APIs have passed multiple international quality validations.03 2026-04

Anticholinergic and emergency treatment APIs have passed multiple international quality validations.

Henan Purui Pharmaceutical Co., Ltd., a company with nearly two decades of experience in the field of specialty active pharmaceutical ingredients (APIs), recently announced that its anticholinergic and emergency
PURE Pharmaceuticals builds a high-end formulation CDMO service platform03 2026-04

PURE Pharmaceuticals builds a high-end formulation CDMO service platform

​Leveraging its deep expertise in active pharmaceutical ingredients (APIs), Henan Pury Pharmaceutical Co., Ltd. has achieved remarkable success
Puri Pharmaceuticals improves its intermediate industry layout03 2026-04

Puri Pharmaceuticals improves its intermediate industry layout

​In the entire pharmaceutical industry chain of "API-Intermediates-Formulation," pharmaceutical intermediates are a crucial link in ensuring product quality and cost advantages.
Deeply cultivate anticholinergic and emergency drug raw materials03 2026-04

Deeply cultivate anticholinergic and emergency drug raw materials

​As a core manufacturer of anticholinergic and emergency APIs in China, Henan Pury Pharmaceutical Co., Ltd. has continuously
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies.Privacy Policy
RejectAccept